Structure-function studies of chemokine-derived carboxy-terminal antimicrobial peptides

Biochimica et Biophysica Acta - Biomembranes

Volumn 1798, Issue 6, 2010, Pages 1062-1072

  Nguyen, Leonard T ^a   Chan, David I ^a   Boszhard, Laura ^b   Zaat, Sebastian A J ^b   Vogel, Hans J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antimicrobial peptide; Chemokine; Host defence peptide; Innate immunity; NMR spectroscopy; Peptide structure; Peptide membrane interactions

Indexed keywords

CHEMOKINE; INTERLEUKIN 8 [53-72]; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA[51-70]; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA[59-70]; NEUTROPHIL ACTIVATING PROTEIN 2 [50-70]; PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; THROMBOCIDIN 1 [50-68]; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; CHEMOKINES; ESCHERICHIA COLI; HUMANS; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77952544839     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2009.11.021     Document Type: Article

References (85)

1. Brown K.L., Hancock R.E. Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 2006, 18:24-30.
2. Dürr M., Peschel A. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect. Immun. 2002, 70:6515-6517.
3. Esche C., Stellato C., Beck L.A. Chemokines: key players in innate and adaptive immunity. J. Invest. Dermatol. 2005, 125:615-628.
4. Hancock R.E., Sahl H.G. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 2006, 24:1551-1557.
5. Meyer J.E., Beier U.H., Gorogh T., Schreiber S., Beck C., Maune S. Defensin and chemokine expression patterns in the palatine tonsil: a model of their local interaction. Eur. Arch. Otorhinolaryngol. 2006, 263:319-326.
6. Pivarcsi A., Nagy I., Koreck A., Kis K., Kenderessy-Szabo A., Szell M., Dobozy A., Kemeny L. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines, and human beta-defensin-2 in vaginal epithelial cells. Microbes Infect. 2005, 7:1117-1127.
7. Bowdish D.M., Davidson D.J., Hancock R.E. Immunomodulatory properties of defensins and cathelicidins. Curr. Top. Microbiol. Immunol. 2006, 306:27-66.
8. Yang D., Biragyn A., Kwak L.W., Oppenheim J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 2002, 23:291-296.
9. Linge H.M., Collin M., Nordenfelt P., Morgelin M., Malmsten M., Egesten A. Granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane disrupting properties and is antibacterial. Antimicrob. Agents Chemother. 2008, 52:2599-2607.
10. Yang D., Chen Q., Hoover D.M., Staley P., Tucker K.D., Lubkowski J., Oppenheim J.J. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J. Leukoc. Biol. 2003, 74:448-455.
11. Yount N.Y., Gank K.D., Xiong Y.Q., Bayer A.S., Pender T., Welch W.H., Yeaman M.R. Platelet microbicidal protein 1: structural themes of a multifunctional antimicrobial peptide. Antimicrob. Agents Chemother. 2004, 48:4395-43404.
12. Lohner K., Prenner E.J. Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems. Biochim. Biophys. Acta 1999, 1462:141-156.
13. Hoover D.M., Boulègue C., Yang D., Oppenheim J.J., Tucker K., Lu W., Lubkowski J. The structure of human macrophage inflammatory protein-3α/CCL20. J. Biol. Chem. 2002, 277:37647-37654.
14. Lehrer R.I., Ganz T. Defensins of vertebrate animals. Curr. Opin. Immunol. 2002, 14:96-102.
15. Maisetta G., Di Luca M., Esin S., Florio W., Brancatisano F.L., Bottai D., Campa M., Batoni G. Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3. Peptides 2007, 29:1-6.
16. Pazgier M., Prahl A., Hoover D.M., Lubkowski J. Studies of the biological properties of human beta-defensin 1. J. Biol. Chem. 2007, 282:1819-1829.
17. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., Anderson M., Schröder J.M., Wang J.M., Howard O.M., Oppenheim J.J. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999, 286:525-528.
18. Baba M., Imai T., Nishimura M., Kakizaki M., Takagi S., Hieshima K., Nomiyama H., Yoshie O. Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J. Biol. Chem. 1997, 272:14893-14898.
19. Schutyser E., Struyf S., Van Damme J., The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003, 14:409-426.
20. Hasan L., Mazzucchelli L., Liebi M., Lis M., Hunger R.E., Tester A., Overall C.M., Wolf M. Function of liver activation-regulated chemokine/CC chemokine ligand 20 is differently affected by cathepsin B and cathepsin D processing. J. Immunol. 2006, 176:6512-6522.
21. Chan D.I., Hunter H.N., Tack B.F., Vogel H.J. Human macrophage inflammatory protein-3{alpha}: protein and peptide NMR solution structures, dimerization, dynamics and anti-infective properties. Antimicrob. Agents Chemother. 2008, 52:883-894.
22. Malik Z.A., Tack B.F. Structure of human MIP-3alpha chemokine. Acta Crystallogr. Sect. F. Struct. Biol. Cyst. Commun. 2006, 62:631-634.
23. Epand R.M., Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1999, 1462:11-28.
24. Tossi A., Sandri L., Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Biopolym 2000, 55:4-30.
25. Haney E.F., Lau F., Vogel H.J. Solution structures and model membrane interactions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin. Biochim. Biophys. Acta 2007, 1768:2355-2364.
26. Haney E.F., Nazmi K., Lau F., Bolscher J.G., Vogel H.J. Novel lactoferrampin antimicrobial peptides derived from human lactoferrin. Biochimie 2008, 91:141-154.
27. Porcelli F., Verardi R., Shi L., Henzler-Wildman K.A., Ramamoorthy A., Veglia G. NMR structure of the cathelicidins-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles. Biochemistry 2008, 47:5565-5572.
28. Bhunia A., Ramamoorthy A., Bhattacharjya S. Helical hairpin structure of a potent antimicrobial peptide MSI-594 in lipopolysaccharide micelles by NMR spectroscopy. Chem. A Eur. J. 2009, 15:2036-2040.
29. Gottler L.M., Ramamoorthy A. Structure, membrane orientation, mechanism, and function of pexiganan-a highly potent antimicrobial peptide designed from magainin. Biochem. Biophys. Acta 2009, 1788:1680-1686.
30. Ramamoorthy A. Beyond NMR spectra of antimicrobial peptides: dynamical images at atomistic resolution and functional insights. Solid State NMR 2009, 35:201-207.
31. Bjorstad A., Fu H., Karlsson A., Dahlgren C., Bylund J. Interleukin-8-derived peptide has antibacterial activity. Antimicrob. Agents Chemother. 2005, 49:3889-3895.
32. Yount N.Y., Waring A.J., Gank K.D., Welch W.H., Kupferwasser D., Yeaman M.R. Structural correlates of antimicrobial efficacy in IL-8 and related human kinocidins. Biochim. Biophys. Acta 2007, 1768:598-608.
33. Schumacher C., Clark-Lewis I., Baggiolini M., Moser B. High- and low-affinity binding of GRO? and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc. Natl. Acad. Sci. 1992, 89:10542-10546.
34. Ehlert J.E., Petersen F., Kubbutat M.H., Gerdes J., Flad H.D., Brandt E. Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). Comparison of native and recombinant NAP-2 variants. J. Biol. Chem. 1995, 270:6338-6344.
35. Krijgsveld J., Zaat S.A.J., Meeldijk J., van Veelen P.A., Fang G., Poolman B., Brandt E., Ehlert J.E., Kuijpers A.J., Engbers G.H.M., Feijen J., Dankert J. Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J. Biol. Chem. 2000, 275:20374-20381.
36. Dankert J., Krijgsveld J., van Der Werff J., Joldersma W., Zaat S.A. Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. J. Infect. Dis. 2001, 184:597-605.
37. Ehlert J.E., Gerdes J., Flad H.-D., Brandt E. Novel C-terminally truncated isoforms of the CXC chemokine β-thromboglobulin and their impact on neutrophil functions. J. Immunol. 1998, 161:4975-4982.
38. Gill S.C., von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 1989, 182:319-326.
39. Sreerama N., Woody R.W. A self-consistent method for the analysis of protein secondary structure from circular dichroism. Anal. Biochem. 1993, 209:32-44.
40. Sreerama N., Woody R.W. Estimation of protein secondary structure from circular dichroism spectra: comparison on CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem. 2000, 287:252-260.
41. Hwang T.L., Shaka A.J. Water suppression that works-excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J. Magn. Reson. A 1995, 112:275-279.
42. Delaglio F., Grzesiek S., Vuister G., Zhu G., Pfeifer G., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6:277-293.
43. Johnson B.A., Blevins R.A. NMRView-a computer-program for the visualization and analysis of NMR data. J. Biomol. NMR 1994, 4:603-614.
44. Wüthrich K. NMR of proteins and nucleic acids 1986, John Wiley & Sons, New York.
45. Linge J.P., O'Donoghue S.I., Nilges M. Automated assignment of ambiguous nuclear Overhauser effects with ARIA. Methods Enzymol. 2001, 339:71-90.
46. Nilges M., O'Donogue S.I. Ambiguous NOEs and automated NOE assignment. Prog. Nucl. Magn. Reson. Spec. 1998, 32:107-139.
47. Laskowski R.A., MacArthur M.W., Moss D.S., Thornton J.M. Procheck-a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26:283-291.
48. Koradi R., Billeter M., Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 1996, 14:51-55.
49. Wimley W.C., White S.H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 1996, 3:842-848.
50. Matsuzaki K., Murase O., Fujii N., Miyajima K. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry 1996, 35:11361-11368.
51. Schibli D.J., Nguyen L.T., Kernaghan S.D., Rekdal O., Vogel H.J. Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures. Biophys. J. 2006, 91:4413-4426.
52. Olson F., Hunt C.A., Szoka F.C., Vail W.J., Papahadjopoulos D. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta 1979, 557:9-23.
53. Ames B.N. Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol. 1966, 8:115-118.
54. Lacroix E., Viguera A.R., Serrano L. Elucidating the folding problem of alpha-helices: Local motifs, long-range electrostatics, ionic-strength dependence and prediction of NMR parameters. J. Mol. Biol. 1998, 284:173-191.
55. Munoz V., Serrano L. Elucidating the folding problem of helical peptides using empirical parameters. Nat. Struct. Biol. 1994, 1:399-409.
56. Dirr H.W., Little T., Kuhnert D.C., Sayed Y. A conserved N-capping motif contributes significantly to the stabilization and dynamics of the C-terminal region of class alpha glutathione S-transferases. J. Biol. Chem. 2005, 280:19480-19487.
57. Stupak M., Zoldak G., Musatov A., Sprinzl M., Sedlak E. Unusual effect of salts on the homodimeric structure of NADH oxidase from Thermus thermophilus in acidic pH. Biochim. Biophys. Acta 2006, 1764:129-137.
58. Boland M.P., Separovic F. Membrane interactions of antimicrobial peptides from Australian tree frogs. Biochim. Biophys. Acta 2006, 1758:1178-1183.
59. Campagna S., Saint N., Molle G., Aumelas A. Structure and mechanism of action of the antimicrobial peptide piscidin. Biochemistry 2007, 46:1771-1778.
60. Gesell J., Zasloff M., Opella S.J. Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an α-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. J. Biomol. NMR 1997, 9:127-135.
61. Buck M. Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins. Q. Rev. Biophys. 1998, 31:297-355.
62. Girvin M.E., Rastogi K.V., Abildgaard F., Markley J.L., Fillingame R.H. Solution structure of the transmembrane H+-transporting subunit c of the F1F0 ATP synthase. Biochemistry 1998, 37:8817-8824.
63. Hunter H.N., Demcoe A.R., Jenssen H., Gutteberg T.J., Vogel H.J. Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent. Antimicrob. Agents Chemother. 2005, 49:3387-3395.
64. Schwaiger M., Lebendiker M., Yerushalmi H., Coles M., Groger A., Schwarz C., Schuldiner S., Kessler H. NMR investigation of the multidrug transporter EmrE, an integral membrane protein. Eur. J. Biochem. 1998, 254:610-619.
65. Rajarathnam K., Clark-Lewis I., Sykes B.D. 1H NMR solution structure of an active monomeric interleukin-8. Biochemistry 1995, 34:12983-12990.
66. Wang W., Smith D.K., Moulding K., Chen H.M. The dependence of membrane permeability by the antibacterial peptide cecropin B and its analogs, CB-1 and CB-3, on liposomes of different composition. J. Biol. Chem. 1998, 273:27438-27448.
67. Hwang P.M., Zhou N., Shan X., Arrowsmith C.H., Vogel H.J. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry 1998, 37:4288-4298.
68. Zhou N., Tieleman D.P., Vogel H.J. Molecular dynamics simulations of bovine lactoferricin: turning a helix into a sheet. Biometals 2004, 17:217-223.
69. Gifford J.L., Hunter H.N., Vogel H.J. Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci. 2005, 62:2588-2598.
70. Wakabayashi H., Takase M., Tomita M. Lactoferricin derived from milk protein lactoferrin. Curr. Pharm. Des. 2003, 9:1277-1287.
71. Yeaman M.R., Yount N.Y., Waring A.J., Gank K.D., Kupferwasser D., Wiese R., Bayer A.S., Welch W.H. Modular determinants of antimicrobial activity in platelet factor-4 family kinocidins. Biochim. Biophys. Acta 2007, 1768:609-619.
72. Castro M.S., Cilli E.M., Fontes W. Combinatorial synthesis and directed evolution applied to the production of alpha-helix forming antimicrobial peptides analogues. Curr. Protein Pept. Sci. 2006, 7:473-478.
73. Chen Y., Guarnieri M.T., Vasil A.I., Vasil M.L., Mant C.T., Hodges R.S. Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob. Agents Chemother. 2007, 51:1398-1406.
74. Zelezetsky I., Tossi A. Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies. Biochim. Biophys. Acta 2006, 1758:1436-1449.
75. Chan D.I., Prenner E.J., Vogel H.J. Tryptophan- and arginine-rich antimicrobial peptides: structures and mechanism of action. Biochim. Biophys. Acta 2006, 1758:1184-1202.
76. Pokorny A., Almeida P.F. Kinetics of dye efflux and lipid flip-flop induced by delta-lysin in phosphatidylcholine vesicles and the mechanism of graded release by amphipathic, alpha-helical peptides. Biochemistry 2004, 43:8846-8857.
77. Respondek M., Madl T., Gobl C., Golser R., Zangger K. Mapping the orientation of helices in micelle-bound peptides by paramagnetic relaxation waves. J. Am. Chem. Soc. 2007, 129:5228-5234.
78. Hunter H.N., Jing W., Schibli D.J., Trinh T., Park I.Y., Kim S.C., Vogel H.J. The interactions of antimicrobial peptides derived from lysozyme with model membrane systems. Biochim. Biophys. Acta 2005, 1668:175-189.
79. Rezansoff A.J., Hunter H.N., Jing W., Park I.Y., Kim S.C., Vogel H.J. Interactions of the antimicrobial peptide Ac-FRWWHR-NH(2) with model membrane systems and bacterial cells. J. Pept. Res. 2005, 65:491-501.
80. Shin S., Kim J.K., Lee J.Y., Jung K.W., Hwang J.S., Lee J., Lee D.G., Kim I., Shin S.Y., Kim Y. Design of potent 9-mer antimicrobial peptide analogs of protaetiamycine and investigation of mechanism of antimicrobial action. J. Pept. Sci. 2009, 15:559-568.
81. Marchand C., Krajewski K., Lee H.F., Antony S., Johnson A.A., Amin R., Roller P., Kvaratskhelia M., Pommier Y. Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites. Nucleic Acids Res. 2006, 34:5157-5165.
82. Lequin O., Ladram A., Chabbert L., Bruston F., Convert O., Vanhoye D., Chassaing G., Nicolas P., Amiche M. Dermaseptin S9, an alpha-helical antimicrobial peptide with a hydrophobic core and cationic termini. Biochemistry 2006, 45:468-480.
83. Malkowski M.G., Wu J.Y., Lazar J.B., Johnson P.H., Edwards B.F. The crystal structure of recombinant human neutrophil-activating peptide-2 (M6L) at 1.9-A resolution. J. Biol. Chem. 1995, 270:7077-7087.
84. Young H., Roongta V., Daly D.J., Mayo K.H. NMR structure and dynamics of monomeric neutrophil-activating peptide 2. Biochem. J. 1999, 338:591-598.
85. Li Q.-J., Yao M., Wong W., Parpura V., Martins-Green M. N- and C-terminal peptides of hIL-8/CXCL8 are ligands for hCXCR1 and hCXCR2. FASEB J. 2004, 18:776-778.